Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Eating symptomatology and personality in first-generation Latin-American immigrants versus Spanish native-born bulimia nervosa patients

  • Forcano, Laura|||0000-0002-8478-1451
  • Santamaría, Juan José|||0000-0001-9957-9363
  • Agüera, Zaida|||0000-0003-4453-4939
  • Gunnard, Katherina
  • Tchanturia, Kate|||0000-0001-8988-3265
  • Krug, Isabel|||0000-0002-5275-3595
  • Treasure, Janet|||0000-0003-0871-4596
  • Granero, Roser|||0000-0001-6308-3198
  • Penelo Werner, Eva|||0000-0001-6796-7660
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
We sought to determine whether differences would be found in eating symptomatology and personality attributes between Latin-American immigrants to Spain and Spanishborn Bulimia nervosa (BN) patients. Method: The participants included 20 first generation Latin-American immigrant and 20 native-born Spanish BN inpatients. Assessment: Measures included the EAT-40, EDI-2, TCIR, and motivational stage of change, as well as other clinical and psychopathological indices. Results: Clinical history was independent of the participants' origin, except for a higher incidence of family history of alcohol dependence among immigrants (p=0.048). Immigrant patients felt less hindered by their disorder (p=0.011) than the native cohort. Although most psychopathological measures showed no significant between-group differences, immigrants reported significantly lower means in the Ineffectiveness (p=0.046) and Body Dissatisfaction (p=0.028) subscales of the EDI-2. No substantial between-group differences were found for personality. Among the immigrants, 62% and 38% presented with pre-migration and post-migration onset of their ED, respectively. No significant differences in eating symptomatology were detected between pre and post migration onset subgroups. Conclusions: The higher scores on the EDI-2 Body Dissatisfaction and Ineffectiveness subscales in Spanishborn BN patients may reflect a greater influence of Western thin body image ideals in this group. The occurrence of post-migration BN in a significant minority of LatinAmerican immigrants to Spain emphasizes the role of acculturation problems in the predisposition to an ED.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Anger in pathological gambling, clinical, psychopathological, and personality correlates

  • Aymamí, Neus|||0000-0002-4607-9565
  • Granero, Roser|||0000-0001-6308-3198
  • Penelo Werner, Eva|||0000-0001-6796-7660
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Krug, Isabel|||0000-0002-5275-3595
  • Gunnard, Katarina|||0000-0002-8002-0997
  • Santamaría, Juan José|||0000-0001-9957-9363
  • Bueno, Blanca
  • Jaurrieta Guarner, Núria
  • Gomez-Peña, Monica|||0000-0001-6194-8266
  • Alvarez Moya, Eva Maria|||0000-0002-3723-3225
  • Claes, Laurence|||0000-0002-2287-3158
  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
The aim of this study was to explore the association between pathological gambling (PG) and anger by assess- ing whether psychopathology and personality are related to PG and to evaluate gender differences. The sample com- prised 71 PGs and 37 healthy controls. Anger, psychopathology and personality were assessed with the STAXI-2, SCL-90-R and TCI-R respectively. Gender did not affect anger expression after stratifying by diagnostic condition (p.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic determinants of testicular sperm extraction outcomes, insights from a large multicentre study of men with non-obstructive azoospermia

  • Riera-Escamilla, Antoni|||0000-0002-4485-3094
  • Arafa, Mohamed M.
  • Farnetani, Ginevra
  • Xavier, Miguel|||0000-0003-0709-7223
  • Oud, Manon S.|||0000-0001-9513-3030
  • Majzoub, Ahmad A.
  • Ramos, Liliana|||0000-0002-4269-013X
  • Abrardo, Chiara|||0000-0002-9577-6025
  • Spinelli, Matilde|||0009-0009-4820-4620
  • Moreno-Mendoza, Daniel
  • Defazio, Giuseppe|||0000-0002-9356-5224
  • Ars, Elisabet|||0000-0002-4118-4358
  • Pybus, Marc|||0000-0002-6195-5738
  • Sánchez-Curbelo, Josvany|||0000-0002-6489-3309
  • Elbardisi, Haitham|||0000-0003-3902-7924
  • Nawaz, Shoaib
  • Syed, Najeeb
  • Ruiz-Castañé, Eduardo|||0000-0002-7469-4610
  • van der Heijden, Godfried W.
  • Fakhro, Khalid A.
  • Veltman, Joris A.|||0000-0002-3218-8250
  • Krausz, Csilla|||0000-0001-6748-8918
What is the diagnostic yield and the pre-testicular sperm extraction (TESE) prognostic value of a non-obstructive azoospermia (NOA)-specific virtual gene panel? The diagnostic yield in our cohort was 6.1%, and by combining our data with published literature, we identified 11 genes compatible with testicular sperm production and 19 genes associated with no sperm retrieval in carriers of pathogenic (P) or likely pathogenic (LP) mutations. Azoospermia, the most severe form of male infertility, affects ∼1% of the male population, with TESE being the primary treatment option. However, in NOA, TESE fails in nearly 50% of cases and existing clinical parameters are unable to predict TESE failure. Over the past decade, next-generation sequencing (NGS) has identified several candidate NOA genes, but their diagnostic utility and impact on TESE outcomes have not been fully explored. A literature search was addressed to identify well-established NOA genes for designing a specific virtual gene panel for NOA. Our retrospective study analysed the diagnostic yield of the NGS-based virtual gene panel, comprising 145 genes, in 571 men affected by idiopathic NOA with known TESE outcomes. Subsequently, a second literature search was performed to identify carriers of LP/P variants in the genes where we identified mutations, focusing on individuals with known TESE outcomes. This approach allowed us to integrate the published data with our findings and predict a genotype-phenotype correlation between the affected genes and TESE success. 571 NOA patients with known TESE outcomes were recruited in two European and one Middle East centres. Variants were obtained from a whole-exome sequencing dataset and crossed with the 145 genes of the virtual gene panel. After a filtering process, variants were manually assessed and classified according to ACMG guidelines by using two methods: (i) In order to compare our data with previously published studies, we applied ACMG-AMP guidelines along with ClinGen recommendations used by other similar studies. (ii) A new approach was used to optimize ACMG-AMP guidelines with all ClinGen recommendations and incorporated NOA-specific rules addressing phenotypic, locus, and allelic heterogeneity. LP and P variants were confirmed by Sanger sequencing. By using the new variant classification approach adapted for NOA, we identified LP/P variants in 6.1% of patients, with a higher yield (9.4%) in cases with negative TESE outcomes and maturation arrest (11.7%). By integrating our findings with the literature, we highlight 19 genes recurrently associated with negative TESE outcomes and 11 genes associated with positive sperm retrieval either in the testis or in semen. TESE is recommended for patients with LP or P variants in the 11 specific genes. Notably, six of these genes are located on the X chromosome, therefore, these variants will be obligatorily transmitted to daughters, and potentially increase the risk of NOA-related infertility in male offspring. We observed that nine genes, in which we identified LP/P variants, have been previously described in individuals with premature ovarian insufficiency (POI). Of these, eight were associated with negative TESE outcomes in men. Furthermore, we propose seven additional genes mutated in our cohort of NOA patients as novel POI candidates. These genes have not yet been considered as POI candidates, but they result in female infertility when knocked out in mouse models. LP/P variants have been submitted to ClinVar (). NOA is genetically heterogeneous, and our panel excludes those genes which were reported only in a single subject or single family. Although this can limit the diagnostic yield in our study, it ensures that only genes with clear relationship with NOA have been analysed. While in our cohort TESE outcomes are known for all patients, this information is often not available for mutation carriers in the published studies. Consequently, the total number of patients with P variants in the same gene remains relatively low, limiting our final conclusions. However, even if the number of carriers of genes associated with positive sperm retrieval is relatively low, it does not constrain our conclusions regarding TESE prediction. On the other hand, caution is warranted for genes linked to negative TESE outcomes, except for TEX11, SYCE1, and MSH4, each of which have 10 or more reported TESE-negative cases. Our study was performed on the largest available NOA cohort with known TESE outcomes. It not only provides an estimate on the diagnostic potential of a NOA-specific virtual gene panel, but it also advances the understanding of genetic factors influencing TESE outcomes. Half of the genes mutated in our study and presenting TESE-positive outcomes are already informative for clinical decision-making. The observed genotype-phenotype correlations may help in personalized decision-making prior to TESE, in order to undergo the procedure or to avoid unnecessary invasive treatment. It provides valuable insights that can inform clinical management strategies and potentially offer personalized treatments based on genetic profiles. The use of two different variant classification methods highlights that previous studies may have over-estimated the diagnostic yield, underscoring the need for a standardized variant classification approach addressed specifically to male infertility. Our study also emphasizes the overlap between NOA- and POI-associated genes, which has important clinical implications for genetic counselling of female siblings of affected individuals. This work was funded by the Spanish Ministry of Health Instituto Carlos III-FIS FONDOS FEDER (grant numbers PI20/01562 and PI23/00425) and the Fanconi Research Fund awarded to C.K. and A.R.-E. This article is based upon work from COST Action CA20119 (ANDRONET), supported by COST (European Cooperation in Science and Technology) (). C.K., A.R.-E., G.F., M.J.X., M.S.O., C.A., M.S., and E.R.-C. are members of the Action. This research was also supported by the Qatar National Research Fund (QNRF) under grant NPRP12S-0318-190394, and by an Investigator Award in Science from the Wellcome Trust (209451 to J.A.V.). The authors declare no competing interests.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lifetime substance abuse, family history of alcohol abuse/dependence and novelty seeking in eating disorders, comparison study of eating disorder subgroups

  • Krug, Isabel|||0000-0002-5275-3595
  • Poyastro Pinheiro, Andrea
  • Bulik, Cynthia M.|||0000-0001-7772-3264
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Granero, Roser|||0000-0001-6308-3198
  • Penelo Werner, Eva|||0000-0001-6796-7660
  • Masuet Augmantell, Cristina|||0000-0001-7000-7345
  • Agüera, Zaida|||0000-0003-4453-4939
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Aim: To assess lifetime substance abuse, family history of alcohol abuse/dependence, and novelty seeking in three different eating disorder groups (anorexia nervosa-restrictive; anorexia nervosa-binge eating/purging; anorexia nervosa to bulimia nervosa). Method: A total sample of 371 eating disorder patients participated in the current study. Assessment measures included the prevalence of substance abuse and family history of alcohol abuse/dependence as well as the novelty-seeking subscale of the Tempera- ment and Character Inventory-Revised. Results: Significant differences across groups were detected for lifetime substance abuse, with anorexia nervosa-restrictive individuals exhibiting a signifi- cant lower prevalence than the anorexia nervosa to bulimia nervosa and anorexia nervosa-binge eating/purging patients (P < 0.01). For family history of alcohol abuse/dependence the same pattern was observed (P = 0.04). Novelty seeking was associated with substance abuse (P = 0.002), with the anorexia nervosa to bulimia nervosa group exhibiting signifi- cantly higher scores on the novelty-seeking scale than the other two groups (P < 0.001). But family history of alcohol abuse/dependence was not related to novelty seeking (P = 0.092). Conclusion: Lifetime substance abuse appears to be more prevalent in anorexia nervosa patients with bulimic features. Higher novelty-seeking scores may be associated with diagnosis cross-over.
Repisalud
Publicación Artículo científico (JournalArticle)

BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis

  • Richart, Laia
  • Carrillo-de-Santa-Pau, Enrique
  • Río-Machín, Ana
  • de Andrés, Mónica P
  • Cigudosa, Juan C
  • Lobo, Víctor J Sánchez-Arévalo
  • Real Arribas, Francisco
c-MYC oncogene is deregulated in most human tumours. Histone marks associated with transcriptionally active genes define high-affinity c-MYC targets. The mechanisms involved in their recognition by c-MYC are unknown. Here we report that c-MYC interacts with BPTF, a core subunit of the NURF chromatin-remodelling complex. BPTF is required for the activation of the full c-MYC transcriptional programme in fibroblasts. BPTF knockdown leads to decreased c-MYC recruitment to DNA and changes in chromatin accessibility. In Bptf-null MEFs, BPTF is necessary for c-MYC-driven proliferation, G1-S progression and replication stress, but not for c-MYC-driven apoptosis. Bioinformatics analyses unveil that BPTF levels correlate positively with c-MYC-driven transcriptional signatures. In vivo, Bptf inactivation in pre-neoplastic pancreatic acinar cells significantly delays tumour development and extends survival. Our findings uncover BPTF as a crucial c-MYC co-factor required for its biological activity and suggest that the BPTF-c-MYC axis is a potential therapeutic target in cancer.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Therapeutic approaches and development of genomic diagnostic tools for Usher syndrome

  • Fuster García, Carla
[ES] El síndrome de Usher (USH) es un trastorno raro autosómico recesivo definido principalmente por sordera neurosensorial (SNHL), y una distrofia retiniana conocida como retinosis pigmentaria (RP). La patología muestra heterogeneidad genética, puesto que se conocen al menos 10 genes responsables. No obstante, las mutaciones en USH2A son la causa más frecuente de la enfermedad, en gran medida por la recurrencia de la variante patogénica c.2299delG. En esta tesis se ha desarrollado un ensayo de edición génica para revertir dicha anomalía genética por medio del sistema CRISPR/Cas9. Se diseñaron y probaron varios complejos CRISPR específicos de locus, y el más eficiente fue usado para la corrección de la mutación c.2299delG en células derivadas de pacientes. La tasa de corrección de la mutación obtenida fue del 2.5%. Otro objetivo de esta tesis ha sido la caracterización genética de pacientes USH aún sin diagnóstico molecular. Una primera fase implicó la secuenciación masiva dirigida de las regiones codificantes de todos los genes asociados a la enfermedad. Este estudio, cuya cohorte incluyó 58 pacientes no escrutados previamente, permitió la identificación de 42 nuevas mutaciones presuntamente patológicas, y una tasa general de detección de alelos responsables de la enfermedad de prácticamente el 83%. Sorprendentemente, uno de los sujetos presentaba mutaciones en CEP250, uno de los últimos genes correlacionados con la enfermedad. Una exhaustiva revisión clínica reveló que la degeneración retiniana se trataba en realidad de una distrofia de conos y bastones en lugar de RP clásica, lo cual permitió consolidación del gen CEP250 como responsable de un fenotipo similar al USH. El resto de casos sin resolver induce a sospechar de la existencia de otros genes vinculados con USH. Así pues, se analizó el exoma íntegro de dichos casos negativos del panel por medio de secuenciación de exoma completo, lo cual proporcionó resultados relevantes en seis de las muestras estudiadas. Uno de tales sujetos resultó ser un claro caso de fenocopia de USH, al albergar mutaciones patogénicas en dos genes independientes, TECTA y REEP6, siendo el primero responsable de la SNHL y el segundo de la RP. De forma parecida, en otro paciente se detectaron variantes patológicas para RP en el gen EYS, pero no se identificó paralelamente ningún cambio genético que explicara la SNHL. Tres individuos adicionales resultaron haber sido erróneamente diagnosticados como USH, dada la conclusiva inexistencia o ambigüedad de la sordera. Uno de ellos fue definido como homocigoto de una mutación en CNGB1, ya reconocido como responsable de RP. En el segundo de dichos sujetos se identificó una mutación en homocigosis en el gen GRN, cuyos defectos en estado heterocigoto están asociados a demencia frontotemporal y más raramente combinada con RP si ambos alelos se encuentran alterados. Por otro lado, el tercer paciente fue resuelto como heterocigoto compuesto de variantes en WDR19, un gen asociado en mayor medida a una distrofia retiniana acompañada de trastornos renales y, más raramente, a la forma aislada del síntoma. En el último de los seis casos resaltados de este objetivo se detectó una mutación homocigota sin sentido en el gen ASIC5, cuyo papel en el organismo todavía se desconoce. Sin embargo, se han correlacionado funciones visuales y auditivas para miembros de la misma familia proteica. En conjunto, los hallazgos obtenidos en este trabajo avalan la importancia del uso de las más novedosas tecnologías en la búsqueda de soluciones para enfermedades raras, las cuales presentan por ahora un pronóstico terapéutico bastante desamparado. Asimismo, otras consecuencias positivas en cuanto a la caracterización genética de los pacientes son la corroboración (o rectificación) del diagnóstico inicial, así como la contribución a la estimación demográfica y correlaciones de genotipo-fenotipo, que en definit, [CA] La síndrome d'Usher (USH) és una malaltia rara autosòmic recessiu definit principalment per sordera neurosensorial (SNHL) i una distròfia retiniana coneguda com a retinosi pigmentària (RP). La patologia mostra heterogeneïtat genètica, ja que es coneixen almenys 10 gens responsables. No obstant això, les mutacions en USH2A són la causa més freqüent de la malaltia, a causa de la recurrència de la variant patogènica c.2299delG. En aquesta tesi s'ha desenvolupat un assaig d'edició gènica per a revertir la dita anomalia genètica per mitjà del sistema CRISPR/Cas9. Es van dissenyar i van probar diversos complexos CRISPR específics de locus, i el més eficient va ser usat per a la correcció de la mutació en cèl·lules derivades de pacients. La taxa de correcció de la mutació obtinguda va ser del 2.5%. Un altre objectiu d'aquesta tesi ha sigut la caracterització genètica de pacients USH encara sense diagnòstic molecular. Una primera fase va implicar la seqüenciació massiva dirigida de les regions codificants de tots els gens associats a la malaltia. Aquest estudi, la cohort de la qual va incloure 58 pacients no escrutats prèviament, va permetre la identificació de 42 noves mutacions presumptament patològiques, i una taxa general de detecció d'al·lels responsables de la malaltia de pràcticament el 83%. Sorprenentment, un dels subjectes presentava mutacions en CEP250, un dels últims gens correlacionats amb la malaltia. Una exhaustiva revisió clínica va revelar que la degeneració retiniana es tractava en realitat d'una distròfia de cons i bastons en lloc de RP clàssica. Aquestes troballes han permés la consolidació del gen CEP250 com a responsable d'un fenotip similar al USH. La resta de casos sense resoldre induïx a sospitar de l'existència d'altres gens vinculats amb USH. Així, doncs, es va analitzar l'exoma íntegre dels casos negatius del panell a través de seqüenciació d'exoma complet, cosa que va proporcionar resultats rellevants en sis de les mostres estudiades. Un de tals subjectes va resultar ser un clar cas de fenocopia d'USH, a l'albergar mutacions patogèniques en dos gens independents, TECTA i REEP6, sent el primer responsable de la SNHL i el segon de la RP. De forma semblant, en un altre pacient es van detectar variants patològiques per a RP al gen EYS, però no es va identificar paral·lelament cap canvi genètic que explicara la SNHL. Tres individus addicionals van resultar haver sigut erròniament diagnosticats com USH, donada la final inexistència o ambigüitat de la sordera. Un d'ells va ser definit com a homozigot d'una mutació en CNGB1, ja reconegut com a responsable de RP. En el segon d'aquestes subjectes es va identificar una mutació en homozigosi en el gen GRN, els defectes del qual estan associats a demència frontotemporal en estat heterozigot, i més rarament en combinació amb RP si ambdós al·lels es troben alterats. D'altra banda, el tercer pacient va ser resolt com a heterozigot compost de variants en WDR19, un gen associat en major grau a una distròfia retiniana acompanyada de trastorns renals i, més rarament, a la forma aïllada del símptoma. En l'últim dels sis casos ressaltats d'aquest objectiu es va detectar una mutació homozigota sense sentit en el gen ASIC5, el paper en l'organisme del qual encara es desconeix. Amb tot, s'han correlacionat funcions visuals i auditives per a membres de la mateixa família proteica. En conjunt, les troballes obtingudes en aquest treball avalen la importància de l'ús de les més noves tecnologies en la recerca de solucions per a malalties rares, les quals presenten per ara un pronòstic terapèutic prou desemparat. Així mateix, altres conseqüències positives quant a la caracterització genètica dels pacients són la corroboració (o rectificació) del diagnòstic inicial, així com la contribució a l'estimació demogràfica i correlacions de genotip-fenotip, que en definitiva ajuden en la compressió d'US, [EN] Usher syndrome (USH) is a rare autosomal recessive disorder defined essentially by sensorineural hearing loss (SNHL) and a retinal dystrophy known as retinitis pigmentosa (RP). The condition shows a genetic heterogeneity, since there are at least 10 genes known to be causative of the syndrome. However, mutations in USH2A are the most frequent cause of the disease, due in a large measure to the recurrence of the c.2299delG pathogenic variant. A gene editing assay to reverse this specific genetic anomaly was developed in this thesis by means of the groundbreaking CRISPR/Cas9 system. Several locus-specific CRISPR complexes were designed and tested, and the most efficient was used to proceed with the c.2299delG mutation correction on patient-derived cells. The trial resulted in a mutation correction rate of 2.5%. Another goal of this thesis was the genetic characterization of molecularly undiagnosed USH patients. Given the genetic diversity of the disease, the procedure required the implementation of high-throughput sequencing, a technology that enables in bulk sequencing of any number of selected loci (or the indiscriminate totality) of the genome. The first phase implied the targeted sequencing of the coding-relevant regions of all known causative or disease-associated genes at the moment. The study, comprising a cohort of 58 previously unscreened patients, enabled the identification of 42 novel putative pathogenic mutations, and an etiologic-allele detection ratio shy of 83%. Remarkably, one of the subjects harbored nonsense mutations in CEP250, which is one of the latest USH-associated genes. However, an exhaustive review of the clinical features unmasked the retinal degeneration as a cone-rod dystrophy rather than RP, which reinforced the linkage of the gene to an USH-like phenotype. The remaining portion of unresolved cases lead to suspicion of the existence of other genes accountable for USH. Hence, the complete exome of such panel-negative cases was screened through whole exome sequencing. This venture provided relevant findings in six of the surveyed samples. One subject was plainly exposed as an USH phenocopy by harboring pathogenic splice-site mutations in two independent genes, TECTA and REEP6, the former responsible for the SNHL and the latter for the RP. Similarly, RP-causative variants in EYS were detected in another patient, yet no pathogenic changes explaining the HL were discovered. Three additional individuals were ultimately unveiled as USH misdiagnosed cases, being the HL actually absent or ambiguous. One of the patients in this set was homozygous for a mutation in CNGB1, already known to be accountable for RP. The other two cases showed a more peculiar outcome being compound heterozygous for putatively pathogenic variants in genes generally associated to other disorders. One presented a homozygous mutation in GRN, a gene associated to frontotemporal dementia under heterozygous condition and less commonly to combined RP for homozygous alterations. The third subject was found to be a carrier of mutations in WDR19, a gene best associated with retinal disorders accompanied by renal signs and rarely with the isolated visual symptom. The last case presented a homozygous nonsense variant in the ASIC5 gene, whose role has yet to be learned. However, some correlations to visual and hearing functions have been reported for members of the same protein family. Altogether, the results obtained from this work attest to the importance of applying the most up-to-date technologies in the search of solutions for rare diseases that realistically pose a despairing therapeutic prognosis. In addition, the positive consequences of the genetic characterization of the patients are the corroboration (or else correction) of the initial diagnosis, and the contribution to the appraisal of demographic and genotype-phenotype correlations, which ultimately aid in the understanding USH and other related diseases., This work was financially supported by the Institute of Health Carlos III and FEDER funds (ISCIII; grants PI13/00638, PI16/00425, PI16/00539, and PIE13/00046), Fundación ONCE (grant 2015/0398), XVIII Fundaluce-FARPE, and “Telemaratón: Todos Somos Raros, Todos Somos Únicos” (grant IP58). C.F.-G. is a recipient of a fellowship (grant IFI14/00021) from the ISCIII. R.P.V.-M. is a Miguel Servet researcher (grant CP11/00090 funded by ISCIII, Madrid, Spain). The funds from the ISCIII are partially supported by the European Regional Development Fund. R.-P.V.M. is also a Marie Curie fellow (grant CIG322034 from the European Commission).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Protein Haploinsufficiency Drivers Identify MYBPC3 Variants That Cause Hypertrophic Cardiomyopathy

  • Suay-Corredera, Carmen
  • Pricolo, María Rosaria
  • Herrero-Galán, Elías
  • Velázquez-Carreras, Diana
  • Sánchez-Ortiz, David
  • García-Giustiniani, Diego
  • Delgado, Javier
  • Galano-Frutos, Juan José
  • García-Cebollada, Helena
  • Vilches, Silvia
  • Domínguez, Fernando
  • Sabater Molina, María
  • Barriales-Villa, Roberto
  • Frisso, Giulia
  • Sancho, Javier
  • Serrano, Luis
  • García-Pavía, Pablo
  • Monserrat, Lorenzo
  • Alegre-Cebollada, Jorge
[Abstract] Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. Variants in MYBPC3, the gene encoding cardiac myosin-binding protein C (cMyBP-C), are the leading cause of HCM. However, the pathogenicity status of hundreds of MYBPC3 variants found in patients remains unknown, as a consequence of our incomplete understanding of the pathomechanisms triggered by HCM-causing variants. Here, we examined 44 nontruncating MYBPC3 variants that we classified as HCM-linked or nonpathogenic according to cosegregation and population genetics criteria. We found that around half of the HCM-linked variants showed alterations in RNA splicing or protein stability, both of which can lead to cMyBP-C haploinsufficiency. These protein haploinsufficiency drivers associated with HCM pathogenicity with 100% and 94% specificity, respectively. Furthermore, we uncovered that 11% of nontruncating MYBPC3 variants currently classified as of uncertain significance in ClinVar induced one of these molecular phenotypes. Our strategy, which can be applied to other conditions induced by protein loss of function, supports the idea that cMyBP-C haploinsufficiency is a fundamental pathomechanism in HCM., J. A.-C. acknowledges funding from the Ministerio de Ciencia e Innovación (MCIN) through grants BIO2014-54768-P; BIO2017-83640-P/MINECO/AEI/FEDER, UE; EIN2019-102966 and RYC-2014-16604, the European Research Area Network on Cardiovascular Diseases (ERA-CVD/ISCIII, Spain MINOTAUR, AC16/00045), and the Comunidad de Madrid (consortium Tec4Bio-CM, S2018/NMT-4443, FEDER). The CNIC is supported by the ISCIII, MCIN, and the Pro CNIC Foundation and was a Severo Ochoa Center of Excellence (SEV-2015-0505). We acknowledge funding from ISCIII to the Centro de Investigación Biomédica en Red (CB16/11/00425). L. S. acknowledges funding from MCIN (BFU2015-63571-P). J. S. acknowledges funding from AEI (PID2019-107293GB-I00), Gobierno de Aragón (E45_17R), and ERDF-InterregV-A POCTEFA, Spain (PIREPRED-EFA086/15). C. S.-C. is the recipient of an FPI-SO predoctoral fellowship BES-2016-076638. M. R. P. was the recipient of a PhD fellowship from the Italian Ministry of Education, Universities and Research, Italy. H. G.-C. is the recipient of an FPU16/04232 doctoral contract from MCIN, Comunidad de Madrid; S2018/NMT-4443, Gobierno de Aragón; E45_17R, Gobierno de Aragón; EFA086/15
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications

  • Perea-Romero, I.
  • Gordo, G.
  • Iancu, I.F.
  • Del Pozo-Valero, M.
  • Almoguera, B.
  • Blanco-Kelly, F.
  • Carreño, E.
  • Jimenez-Rolando, B.
  • Lopez-Rodriguez, R.
  • Lorda-Sanchez, I.
  • Martin-Merida, I.
  • Pérez de Ayala, L.
  • Riveiro-Alvarez, R.
  • Rodriguez-Pinilla, E.
  • Tahsin-Swafiri, S.
  • Trujillo-Tiebas, M.J.
  • Bustamante-Aragones, A.
  • Cardero-Merlo, R.
  • Fernandez-Sanchez, R.
  • Gallego-Merlo, J.
  • Garcia-Vara, I.
  • Gimenez-Pardo, A.
  • Horcajada-Burgos, L.
  • Infantes-Barbero, F.
  • Lantero, E.
  • Lopez-Martinez, M.A.
  • Martinez-Ramas, A.
  • Ondo, L.
  • Rodriguez de Alba, M.
  • Sanchez-Jimeno, C.
  • Velez-Monsalve, C.
  • Villaverde, C.
  • Zurita, O.
  • Aguilera-Garcia, D.
  • Aguirre-Lamban, J.
  • Arteche, A.
  • Cantalapiedra, D.
  • Fernandez-San Jose, P.
  • Galbis-Martinez, L.
  • Garcia-Hoyos, M.
  • Lombardia, C.
  • Lopez-Molina, M.I.
  • Perez-Carro, R.
  • Da Silva, L.R.J.
  • Ramos, C.
  • Sanchez-Alcudia, R.
  • Sanchez-Navarro, I.
  • Tatu, S.D.
  • Vallespin, E.
  • Aller, E.
  • Bernal, S.
  • Gamundi, M.J.
  • Garcia-Garcia, G.
  • Hernan, I.
  • Jaijo, T.
  • Antiñolo, G.
  • Baiget, M.
  • Carballo, M.
  • Millan, J.M.
  • Valverde, D.
  • Allikmets, R.
  • Banfi, S.
  • Cremers, F.P.M.
  • Collin, R.W.J.
  • De Baere, E.
  • Hakonarson, H.
  • Kohl, S.
  • Rivolta, C.
  • Sharon, D.
  • Alonso-Cerezo, M.C.
  • Ballesta-Martinez, M.J.
  • Beltran, S.
  • Benito Lopez, C.
  • Català-Mora, J.
  • Catalli, C.
  • Cotarelo-Perez, C.
  • Fernandez-Burriel, M.
  • Fontalba-Romero, A.
  • Galán-Gómez, E.
  • Garcia-Barcina, M.
  • Garcia-Cruz, L.M.
  • Gener, B.
  • Gil-Fournier, B.
  • Govea, N.
  • Guillen-Navarro, E.
  • Hernando Acero, I.
  • Irigoyen, C.
  • Izquierdo-Álvarez, S.
  • Llano-Rivas, I.
  • López-Ariztegui, M.A.
  • Lopez-Gonzalez, V.
  • Lopez-Grondona, F.
  • Martorell, L.
  • Mendez-Perez, P.
  • Moreno-Igoa, M.
  • Oancea-Ionescu, R.
  • Palau-Martinez, F.
  • Perez de Nanclares, G.
  • Ramos-Fuentes, F.J.
  • Rodriguez-Lopez, R.
  • Rodriguez-Pedreira, M.
  • Rodriguez-Peña, L.
  • Rodriguez-Sanchez, B.
  • Rosell, J.
  • Rosello, N.
  • Saez-Villaverde, R.
  • Santana, A.
  • Valenzuela-Palafoll, I.
  • Villota-Deleu, E.
  • Garcia-Sandoval, B.
  • Minguez, P.
  • Avila-Fernandez, A.
  • Corton, M.
  • Ayuso, C.
Inherited retinal diseases (IRDs), defined by dysfunction or progressive loss of photoreceptors, are disorders characterized by elevated heterogeneity, both at the clinical and genetic levels. Our main goal was to address the genetic landscape of IRD in the largest cohort of Spanish patients reported to date. A retrospective hospital-based cross-sectional study was carried out on 6089 IRD affected individuals (from 4403 unrelated families), referred for genetic testing from all the Spanish autonomous communities. Clinical, demographic and familiar data were collected from each patient, including family pedigree, age of appearance of visual symptoms, presence of any systemic findings and geographical origin. Genetic studies were performed to the 3951 families with available DNA using different molecular techniques. Overall, 53.2% (2100/3951) of the studied families were genetically characterized, and 1549 different likely causative variants in 142 genes were identified. The most common phenotype encountered is retinitis pigmentosa (RP) (55.6% of families, 2447/4403). The most recurrently mutated genes were PRPH2, ABCA4 and RS1 in autosomal dominant (AD), autosomal recessive (AR) and X-linked (XL) NON-RP cases, respectively; RHO, USH2A and RPGR in AD, AR and XL for non-syndromic RP; and USH2A and MYO7A in syndromic IRD. Pathogenic variants c.3386G > T (p.Arg1129Leu) in ABCA4 and c.2276G > T (p.Cys759Phe) in USH2A were the most frequent variants identified. Our study provides the general landscape for IRD in Spain, reporting the largest cohort ever presented. Our results have important implications for genetic diagnosis, counselling and new therapeutic strategies to both the Spanish population and other related populations.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic population structure defines wild boar as an urban exploiter species in Barcelona, Spain

  • Hagemann, J.
  • Conejero Fuentes, Carles|||0000-0001-6830-6880
  • Stillfried, M.
  • Mentaberre García, Gregorio|||0000-0001-9542-7514
  • Castillo Contreras, Raquel|||0000-0002-5770-7264
  • Fickel, J.
  • López Olvera, Jorge R.|||0000-0002-2999-3451
Urban wildlife ecology is gaining relevance as metropolitan areas grow throughout the world, reducing natural habitats and creating new ecological niches. However, knowledge is still scarce about the colonisation processes of such urban niches, the establishment of new communities, populations and/or species, and the related changes in behaviour and life histories of urban wildlife. Wild boar (Sus scrofa) has successfully colonised urban niches throughout Europe. The aim of this study is to unveil the processes driving the establishment and maintenance of an urban wild boar population by analysing its genetic structure. A set of 19 microsatellite loci was used to test whether urban wild boars in Barcelona, Spain, are an isolated population or if gene flow prevents genetic differentiation between rural and urban wild boars. This knowledge will contribute to the understanding of the effects of synurbisation and the associated management measures on the genetic change of large mammals in urban ecosystems. Despite the unidirectional gene flow from rural to urban areas, the urban wild boars in Barcelona form an island population genotypically differentiated from the surrounding rural ones. The comparison with previous genetic studies of urban wild boar populations suggests that forest patches act as suitable islands for wild boar genetic differentiation. Previous results and the genetic structure of the urban wild boar population in Barcelona classify wild boar as an urban exploiter species. These wild boar peri-urban island populations are responsible for conflict with humans and thus should be managed by reducing the attractiveness of urban areas. The management of peri-urban wild boar populations should aim at reducing migration into urban areas and preventing phenotypic changes (either genetic or plastic) causing habituation of wild boars to humans and urban environments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessing the epidemiological risk at the human-wild boar interface through a one health approach using an agent-based model in Barcelona, Spain

  • González-Crespo, Carlos|||0000-0003-4312-0398
  • Martínez-López, Beatriz|||0000-0002-7162-2582
  • Conejero Fuentes, Carles|||0000-0001-6830-6880
  • Castillo Contreras, Raquel|||0000-0002-5770-7264
  • Serrano Ferron, Emmanuel|||0000-0002-9799-9804
  • López-Martín, Josep Maria|||0000-0001-8162-3960
  • Serra-Cobo, Jordi
  • Lavín González, Santiago|||0000-0001-5655-588X
  • López Olvera, Jorge R.|||0000-0002-2999-3451
Wild boar (WB, Sus scrofa) populations are increasing in urban areas, posing an epidemiological risk for zoonotic pathogens such as hepatitis E virus (HEV) and antimicrobial-resistant Campylobacter (AMR-CAMP), as well as non-zoonotic pathogens such as African swine fever virus (ASFV). An epidemiological extension of a validated Agent-Based Model (ABM) was developed to assess the one-year epidemiological scenarios of HEV, AMR-CAMP, and ASFV in the synurbic WB-human interface in Barcelona, Spain. The predicted citizen exposure was similar for HEV and AMR-CAMP, at 0.79% and 0.80% of the human population in Barcelona, respectively, despite AMR-CAMP being more prevalent in the WB population than HEV. This suggests a major role of faeces in pathogen transmission to humans in urban areas, resulting in a non-negligible public health risk. The ASFV model predicted that the entire WB population would be exposed to the virus through carcasses (87.6%) or direct contact (12.6%) in 51-71 days after the first case, with an outbreak lasting 71-124 days and reducing the initial WB population by 95%. The ABM predictions are useful for animal and public health risk assessments and to support risk-based decision-making. The study underscores the need for interdisciplinary cooperation among animal, public, and environmental health managers, and the implementation of the One Health approach to address the epidemiological and public health risks posed by the synurbization of WB in urban areas. The spatially explicit epidemiological predictions of the ABM can be adapted to other diseases and scenarios at the wildlife-livestock-human interface.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Predicting human-wildlife interaction in urban environments through agent-based models

  • González-Crespo, Carlos|||0000-0003-4312-0398
  • Martínez-López, Beatriz|||0000-0002-7162-2582
  • Conejero Fuentes, Carles|||0000-0001-6830-6880
  • Castillo Contreras, Raquel|||0000-0002-5770-7264
  • Serrano Ferron, Emmanuel|||0000-0002-9799-9804
  • López-Martín, Josep Maria|||0000-0001-8162-3960
  • Lavín González, Santiago|||0000-0001-5655-588X
  • López Olvera, Jorge R.|||0000-0002-2999-3451
Synurbic species adapt to global urbanization by increasingly inhabiting urban environments, where social and ecological factors, such as anthropogenic food resources and habitat alterations, promote close human-wildlife interactions. Ineffective management of these interactions can result in conflicts, altered animal population dynamics, and increased public and private expenditures. This study presents the Barcelona wild boar (BCNWB)-prototype model, a spatially explicit, incremental agent-based simulation that captures interactions between citizens and wild boar (Sus scrofa) agents in fine-scale GIS-based scenarios in Barcelona. Developed using GAMA software, the model's results were analyzed with QGIS and R software. The model aims to simulate the dynamics of the social-ecological system underlying the urban ecosystem use by synurbic wild boars and their interactions with humans in the (peri)urban area of Barcelona, Spain. The BCNWB-prototype model demonstrated high accuracy in predicting the magnitude and location of wild boar movements (multiple-resolution-goodness-of-fit = 0.73) compared to reported wild boar presences in Barcelona. The model also forecasted 115 attack events and 1,442 direct feeding events during a one-year simulation period, as compared to the actual 150 attacks and 1,858 feeding events reported annually. The model's strong performance highlights its potential as a predictive tool for identifying priority areas for human-wild boar interactions and conflicts. Additionally, the model could be employed to assess the cost-effectiveness of management strategies and evaluate the spread, transmission risks, and public health implications of pathogens carried by wild boars.